Literature DB >> 29929975

Beyond the Cardiomyocyte: Consideration of HIPPO Pathway Cell-Type Specificity.

Dominic P Del Re1.   

Abstract

Entities:  

Keywords:  cardiovascular diseases; fibroblasts; inflammation; myocardial infarction; regeneration

Mesh：

Substances：

Year:  2018        PMID： 29929975      PMCID： PMC6053276          DOI： 10.1161/CIRCRESAHA.118.313383

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice.

Authors:  Dominic P Del Re; Takahisa Matsuda; Peiyong Zhai; Shumin Gao; Geoffrey J Clark; Louise Van Der Weyden; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation.

Authors:  Shuai Wang; Feng Xie; Feng Chu; Zhengkui Zhang; Bing Yang; Tong Dai; Liang Gao; Lin Wang; Li Ling; Junling Jia; Hans van Dam; Jin Jin; Long Zhang; Fangfang Zhou
Journal:  Nat Immunol       Date:  2017-05-08       Impact factor: 25.606

3.  The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells.

Authors:  Jing Geng; Shujuan Yu; Hao Zhao; Xiufeng Sun; Xun Li; Ping Wang; Xiaolin Xiong; Lixin Hong; Changchuan Xie; Jiahui Gao; Yiran Shi; Jiaqi Peng; Randy L Johnson; Nengming Xiao; Linrong Lu; Jiahuai Han; Dawang Zhou; Lanfen Chen
Journal:  Nat Immunol       Date:  2017-05-15       Impact factor: 25.606

4.  YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation.

Authors:  Jongshin Kim; Yoo Hyung Kim; Jaeryung Kim; Do Young Park; Hosung Bae; Da-Hye Lee; Kyun Hoo Kim; Seon Pyo Hong; Seung Pil Jang; Yoshiaki Kubota; Young-Guen Kwon; Dae-Sik Lim; Gou Young Koh
Journal:  J Clin Invest       Date:  2017-08-14       Impact factor: 14.808

5.  Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.

Authors:  Xu Feng; Peng Liu; Xin Zhou; Meng-Tian Li; Fu-Long Li; Zhen Wang; Zhipeng Meng; Yi-Ping Sun; Ying Yu; Yue Xiong; Hai-Xin Yuan; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

6.  Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.

Authors:  Yang Xiao; Matthew C Hill; Min Zhang; Thomas J Martin; Yuka Morikawa; Suya Wang; Alexander R Moise; Joshua D Wythe; James F Martin
Journal:  Dev Cell       Date:  2018-04-23       Impact factor: 12.270

7.  Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL.

Authors:  Dominic P Del Re; Takahisa Matsuda; Peiyong Zhai; Yasuhiro Maejima; Mohit Raja Jain; Tong Liu; Hong Li; Chiao-Po Hsu; Junichi Sadoshima
Journal:  Mol Cell       Date:  2014-05-08       Impact factor: 17.970

8.  Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model.

Authors:  Zhiqiang Lin; Alexander von Gise; Pingzhu Zhou; Fei Gu; Qing Ma; Jianming Jiang; Allan L Yau; Jessica N Buck; Katryna A Gouin; Pim R R van Gorp; Bin Zhou; Jinghai Chen; Jonathan G Seidman; Da-Zhi Wang; William T Pu
Journal:  Circ Res       Date:  2014-05-15       Impact factor: 17.367

9.  Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade.

Authors:  Qian Zhang; Fansen Meng; Shasha Chen; Steven W Plouffe; Shiying Wu; Shengduo Liu; Xinran Li; Ruyuan Zhou; Junxian Wang; Bin Zhao; Jianming Liu; Jun Qin; Jian Zou; Xin-Hua Feng; Kun-Liang Guan; Pinglong Xu
Journal:  Nat Cell Biol       Date:  2017-03-27       Impact factor: 28.824

10.  Hippo pathway deficiency reverses systolic heart failure after infarction.

Authors:  John P Leach; Todd Heallen; Min Zhang; Mahdis Rahmani; Yuka Morikawa; Matthew C Hill; Ana Segura; James T Willerson; James F Martin
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962
View more
  4 in total

1.  SLIT3 deficiency attenuates pressure overload-induced cardiac fibrosis and remodeling.

Authors:  Lianghui Gong; Shuyun Wang; Li Shen; Catherine Liu; Mena Shenouda; Baolei Li; Xiaoxiao Liu; John A Shaw; Alan L Wineman; Yifeng Yang; Dingding Xiong; Anne Eichmann; Sylvia M Evans; Stephen J Weiss; Ming-Sing Si
Journal:  JCI Insight       Date:  2020-06-18

Review 2.  Targeting the Hippo pathway in heart repair.

Authors:  Fansen Meng; Bing Xie; James F Martin
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

Review 3.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 4.  Emerging therapeutic targets for cardiac arrhythmias: role of STAT3 in regulating cardiac fibroblast function.

Authors:  Nehal J Patel; Drew M Nassal; Daniel Gratz; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2020-11-23       Impact factor: 6.902
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.